Search
iRhythm Technologies Inc
IRTCAdd to Watchlist
108.010USD
+0.340+0.32%
Close 07-23 16:00（ET）Quotes delayed by 15 min
3.49BMarket Cap
LossP/E TTM
More Details of iRhythm Technologies Inc Company
iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry (MCT) monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.
iRhythm Technologies Inc Info
Ticker SymbolIRTC
Company nameiRhythm Technologies Inc
IPO dateOct 20, 2016
CEOBlackford (Quentin S)
Number of employees2000
Security typeOrdinary Share
Fiscal year-endOct 20
Address699 8th Street
CitySAN FRANCISCO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code94103
Phone14156325700
Websitehttps://www.irhythmtech.com/
Ticker SymbolIRTC
IPO dateOct 20, 2016
CEOBlackford (Quentin S)
Company Executives of iRhythm Technologies Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Quentin S. Blackford
Mr. Quentin S. Blackford
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
120.88K
+0.15%
Ms. Sumi Shrishrimal
Ms. Sumi Shrishrimal
Executive Vice President, Chief Risk Officer
Executive Vice President, Chief Risk Officer
40.03K
-4.29%
Dr. Minang (Mintu) Turakhia, M.D.
Dr. Minang (Mintu) Turakhia, M.D.
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
25.13K
-5.66%
Mr. Mervin Smith
Mr. Mervin Smith
Executive Vice President - Business Operations
Executive Vice President - Business Operations
23.03K
-17.10%
Mr. Abhijit Y. (Abhi) Talwalkar
Mr. Abhijit Y. (Abhi) Talwalkar
Independent Chairman of the Board
Independent Chairman of the Board
20.51K
+7.67%
Mr. Bruce G. Bodaken
Mr. Bruce G. Bodaken
Independent Director
Independent Director
12.85K
+12.24%
Mr. Daniel G. (Dan) Wilson
Mr. Daniel G. (Dan) Wilson
Chief Financial Officer
Chief Financial Officer
12.26K
-35.00%
Dr. Ralph Snyderman, M.D.
Dr. Ralph Snyderman, M.D.
Independent Director
Independent Director
11.45K
+11.86%
Karen Ling ,
Karen Ling ,
Independent Director
Independent Director
9.78K
+16.08%
Dr. Cathleen Noel Bairey Merz, M.D.
Dr. Cathleen Noel Bairey Merz, M.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Quentin S. Blackford
Mr. Quentin S. Blackford
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
120.88K
+0.15%
Ms. Sumi Shrishrimal
Ms. Sumi Shrishrimal
Executive Vice President, Chief Risk Officer
Executive Vice President, Chief Risk Officer
40.03K
-4.29%
Dr. Minang (Mintu) Turakhia, M.D.
Dr. Minang (Mintu) Turakhia, M.D.
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
25.13K
-5.66%
Mr. Mervin Smith
Mr. Mervin Smith
Executive Vice President - Business Operations
Executive Vice President - Business Operations
23.03K
-17.10%
Mr. Abhijit Y. (Abhi) Talwalkar
Mr. Abhijit Y. (Abhi) Talwalkar
Independent Chairman of the Board
Independent Chairman of the Board
20.51K
+7.67%
Mr. Bruce G. Bodaken
Mr. Bruce G. Bodaken
Independent Director
Independent Director
12.85K
+12.24%
FAQs
Who are the top five shareholders of iRhythm Technologies Inc?
The top five shareholders of iRhythm Technologies Inc are: Mr. Quentin S. Blackford
How many institutions hold shares of iRhythm Technologies Inc (IRTC)?
As of 2026Q1, 673 institutions hold shares of iRhythm Technologies Inc, with a combined market value of approximately 35.19M, accounting for 107.08% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -2933991.00.
What is the biggest source of revenue for iRhythm Technologies Inc?
In 2026Q1, the Commercial Payors business generated the highest revenue for iRhythm Technologies Inc, amounting to 392.23M and accounting for 52.50% of total revenue.